Zimmer Biomet to Buy Paragon 28 for $1.1 Billion
(Reuters) -Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion to expand its portfolio of orthopedic surgical devices. The deal will give Zimmer Biomet access to Paragon's surgical implants and equipment used to treat foot and ankle ailments.
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $13.4, a ...
Zacks.com on MSN14h
Strength Seen in Paragon 28, Inc. (FNA): Can Its 8.3% Jump Turn into More Strength?Paragon 28, Inc. (FNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...
Stephens analysts adjusted their stance on Paragon 28 , Inc. (NYSE:FNA), downgrading the stock from Overweight to Equal ...
NEW YORK CITY, NY / ACCESS Newswire / January 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of ...
William Blair has recently reduced Paragon 28 Inc (FNA) stock to Mkt Perform rating, as announced on Today, according to Finviz. Earlier, on Today, Needham had reduced the stock from a Buy to Hold.
Fintel on MSN1d
Needham Downgrades Paragon 28 (FNA)Fintel reports that on January 29, 2025, Needham downgraded their outlook for Paragon 28 (NYSE:FNA) from Buy to Hold. Analyst ...
Canaccord analyst Caitlin Cronin downgraded Paragon 28 (FNA) to Hold from Buy with a price target of $13, down from $15, after Zimmer Biomet ...
MVM Partners, LLC, a significant stakeholder in Paragon 28, Inc. (NASDAQ:FNA), disclosed the sale of 111,465 shares of common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback